2024 annual financial data
Phio Pharmaceuticals 2024 Net income growth
Direct answer
Net income growth was 33.96%.
Operating income was -7,387,000 USD and net income was -7,150,000 USD.
Operating cash flow was -7,112,000 USD.
Get free Phio Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,387,000 USD
- Net income
- -7,150,000 USD
- Operating cash flow
- -7,112,000 USD